What is the new miracle Osicent 80 mg (Osimertinib) drug for lung cancer?
Lung cancer is one of the most prevalent and deadliest forms of cancer worldwide. In recent years, advancements in targeted therapy have significantly improved treatment outcomes, particularly for patients with non-small cell lung cancer (NSCLC). One such revolutionary medication is Osicent 80 mg (Osimertinib), a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). […]
